Machine Learning-Guided Virtual Screening Identifies a Novel MELK-Targeted Antiproliferative Lead Compound with G2/M Arrest Activity in Triple-Negative Breast Cancer and Lung Adenocarcinoma Cells.
Cao W, Jiang B, Chi X, Li W, Yang H, Li X, Zhao Y, Zhang X, Meng R, Cang Y, Du G, Wang J
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.